Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Department of Neurosurgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Eur Radiol. 2024 Apr;34(4):2183-2194. doi: 10.1007/s00330-023-10251-9. Epub 2023 Oct 5.
To investigate the relationship of followings for patients with moyamoya disease (MMD): arterial wall enhancement on vessel wall MRI (VW-MRI), cross-sectional area (CSA), time-of-flight MR angiography (MRA), age, locations from intracranial internal carotid artery (ICA) to proximal middle cerebral artery (MCA), disease progression, and transient ischemic attack (TIA).
Patients who underwent VW-MRI between October 2018 and December 2020 were enrolled in this retrospective study. We measured arterial wall enhancement (enhancement ratio, ER) and CSA at five sections of ICA and MCA. Also, we scored MRA findings. Multiple linear regression (MLR) analysis was performed to explore the associations between ER, age, MRA score, CSA, history of TIA, and surgical revascularization.
We investigated 102 sides of 51 patients with MMD (35 women, 16 men, mean age 31 years ± 18 [standard deviation]). ER for MRA score 2 (signal discontinuity) was higher than ER for other scores in sections D (end of ICA) and E (proximal MCA) on MLR analysis. ER in section E was significantly higher in patients for MRA score 2 with TIA history than without. ER significantly increased as CSA increased in section E, which suggests ER becomes less in decreased CSA due to negative remodeling.
Arterial wall enhancement in MMD varies by age, location, and disease progression. Arterial wall enhancement may be stronger in the progressive stage of MMD. Arterial wall enhancement increases with history of TIA at proximal MCA, which may indicate the progression of the disease.
Arterial wall enhancement in moyamoya disease varies by age, location of arteries, and disease progression, and arterial wall enhancement may be used as an imaging biomarker of moyamoya disease.
It has not been clarified what arterial wall enhancement in moyamoya disease represents. Arterial wall enhancement in moyamoya disease varies by age, location of arteries, and disease progression. Arterial wall enhancement in moyamoya disease increases as the disease progresses.
探讨磁共振血管壁成像(VW-MRI)上的动脉壁强化、血管横截面积(CSA)、磁共振血管成像(MRA)、年龄、颈内动脉(ICA)颅内段到大脑中动脉(MCA)近端的距离、疾病进展和短暂性脑缺血发作(TIA)与烟雾病(MMD)患者的关系。
本回顾性研究纳入了 2018 年 10 月至 2020 年 12 月期间接受 VW-MRI 检查的患者。我们测量了 ICA 和 MCA 五个节段的动脉壁强化(强化比,ER)和 CSA。同时,我们对 MRA 结果进行了评分。采用多元线性回归(MLR)分析探讨 ER、年龄、MRA 评分、CSA、TIA 病史和血管重建术之间的关系。
共纳入了 51 例 MMD 患者的 102 侧,其中 35 例为女性,16 例为男性,平均年龄 31 岁±18 岁(标准差)。MLR 分析显示,MRA 评分为 2 分(信号中断)的患者在 D 段(ICA 末端)和 E 段(MCA 近端)的 ER 高于其他评分。在有 TIA 病史的 MRA 评分为 2 分的患者中,E 段的 ER 显著更高。E 段的 ER 随 CSA 的增加而显著增加,这表明由于负性重塑,CSA 减小导致 ER 减少。
MMD 的动脉壁强化随年龄、部位和疾病进展而变化。在 MMD 的进展阶段,动脉壁强化可能更强。MCA 近端有 TIA 病史的患者动脉壁强化增加,这可能表明疾病在进展。
烟雾病的动脉壁强化因年龄、动脉位置和疾病进展而异,动脉壁强化可能作为烟雾病的影像学生物标志物。
烟雾病的动脉壁强化代表什么尚不清楚。烟雾病的动脉壁强化随年龄、动脉位置和疾病进展而变化。烟雾病的动脉壁强化随疾病进展而增加。